Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing

被引:110
作者
Dumpa, Nagi Reddy [1 ]
Bandari, Suresh [1 ]
Repka, Michael A. [1 ,2 ]
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmaceut & Drug Delivery, Oxford, MS 38677 USA
[2] Univ Mississippi, Pii Ctr Pharmaceut Innovat & Instruct, Oxford, MS 38677 USA
基金
美国国家卫生研究院;
关键词
hot-melt extrusion; fused deposition modeling; 3D printing; floating systems; pulsatile release; chronotherapeutic delivery; RELEASE; FORMULATION; TABLETS; TECHNOLOGY; DOSAGE;
D O I
10.3390/pharmaceutics12010052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was performed to develop novel core-shell gastroretentive floating pulsatile drug delivery systems using a hot-melt extrusion-paired fused deposition modeling (FDM) 3D printing and direct compression method. Hydroxypropyl cellulose (HPC) and ethyl cellulose (EC)-based filaments were fabricated using hot-melt extrusion technology and were utilized as feedstock material for printing shells in FDM 3D printing. The directly compressed theophylline tablet was used as the core. The tablet shell to form pulsatile floating dosage forms with different geometries (shell thickness: 0.8, 1.2, 1.6, and 2.0 mm; wall thickness: 0, 0.8, and 1.6 mm; and % infill density: 50, 75, and 100) were designed, printed, and evaluated. All core-shell tablets floated without any lag time and exhibited good floating behavior throughout the dissolution study. The lag time for the pulsatile release of the drug was 30 min to 6 h. The proportion of ethyl cellulose in the filament composition had a significant (p < 0.05) effect on the lag time. The formulation (2 mm shell thickness, 1.6 mm wall thickness, 100% infill density, 0.5% EC) with the desired lag time of 6 h was selected as an optimized formulation. Thus, FDM 3D printing is a potential technique for the development of complex customized drug delivery systems for personalized pharmacotherapy.
引用
收藏
页数:13
相关论文
共 37 条
[1]   Development of a floating drug delivery system with superior buoyancy in gastric fluid using hot-melt extrusion coupled with pressurized CO2 [J].
Almutairy, B. K. ;
Alshetaili, A. S. ;
Ashour, E. A. ;
Patil, H. ;
Tiwari, R. V. ;
Alshehri, S. M. ;
Repka, M. A. .
PHARMAZIE, 2016, 71 (03) :128-133
[2]   Development of Floating-Mucoadhesive Microsphere for Site Specific Release of Metronidazole [J].
Amin, Md. Lutful ;
Ahmed, Tajnin ;
Mannan, Md. Abdul .
ADVANCED PHARMACEUTICAL BULLETIN, 2016, 6 (02) :195-200
[3]   Development of an Ointment Formulation Using Hot-Melt Extrusion Technology [J].
Bhagurkar, Ajinkya M. ;
Angamuthu, Muralikrishnan ;
Patil, Hemlata ;
Tiwari, Roshan V. ;
Maurya, Abhijeet ;
Hashemnejad, Seyed Meysam ;
Kundu, Santanu ;
Murthy, S. Narasimha ;
Repka, Michael A. .
AAPS PHARMSCITECH, 2016, 17 (01) :158-166
[4]  
Butreddy A, 2015, ASIAN J PHARM, V9, P290
[5]   Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone [J].
Chai, Xuyu ;
Chai, Hongyu ;
Wang, Xiaoyu ;
Yang, Jingjing ;
Li, Jin ;
Zhao, Yan ;
Cai, Weimin ;
Tao, Tao ;
Xiang, Xiaoqiang .
SCIENTIFIC REPORTS, 2017, 7
[6]   Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages [J].
Chen, Di ;
Xu, Xiang-Yu ;
Li, Rui ;
Zang, Gen-Ao ;
Zhang, Yue ;
Wang, Ming-Rui ;
Xiong, Meng-Fei ;
Xu, Jia-Rui ;
Wang, Ting ;
Fu, Hui ;
Hu, Qin ;
Wu, Bin ;
Yan, Guang-Rong ;
Fan, Tian-Yuan .
AAPS PHARMSCITECH, 2020, 21 (01)
[7]  
Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.3.CO
[8]  
2-N
[9]   Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology [J].
Dumpa, Nagi Reddy ;
Sarabu, Sandeep ;
Bandari, Suresh ;
Zhang, Feng ;
Repka, Michael A. .
AAPS PHARMSCITECH, 2018, 19 (06) :2700-2709
[10]   3D printing of vaginal rings with personalized shapes for controlled release of progesterone [J].
Fu, Junhui ;
Yu, Xiang ;
Jin, Yiguang .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 539 (1-2) :75-82